SQI Diagnostics (SQI Diagnostics) Total Receivables : $0.32 Mil (As of Mar. 2023)

View and export this data going back to 2009. Start your Free Trial

What is SQI Diagnostics Total Receivables?

SQI Diagnostics's Total Receivables for the quarter that ended in Mar. 2023 was $0.32 Mil.

SQI Diagnostics Total Receivables Historical Data

The historical data trend for SQI Diagnostics's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SQI Diagnostics Total Receivables Chart

SQI Diagnostics Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Total Receivables

Get a 7-Day Free Trial

0.76

0.15

0.36

0.16

0.28

SQI Diagnostics Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Total Receivables	Get a 7-Day Free Trial															1.07	0.24	0.28	0.15	0.32

SQI Diagnostics Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

SQI Diagnostics Total Receivables Related Terms

Thank you for viewing the detailed overview of SQI Diagnostics's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

SQI Diagnostics (SQI Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SQI Diagnostics Inc (OTCPK:SQIDF) » Definitions » Total Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

36 Meteor Drive, Toronto, ON, CAN, M9W 1A4

Website

https://www.sqidiagnostics.com

SQI Diagnostics Inc is the leader in the field of lung health. The company develops and manufactures respiratory health and precision medicine tests that run on SQI's automated systems. The company is developing tests to simplify and improve COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada, and Europe. Canada accounts for more than half of its revenues.